THERMO FISHER SCIENTIFIC INC. (TMO)
Thermo Fisher Scientific Inc. (NYSE: TMO) is an American life sciences and biotechnology company headquartered in Waltham, Massachusetts. It provides scientific instruments, laboratory equipment, reagents, chemicals, and analytical services used in pharmaceutical research, biotechnology, clinical diagnostics, and healthcare. Its major businesses include analytical instruments, life sciences solutions, laboratory products and services, and specialty diagnostics.
| Ticker | TMO |
|---|
| Company | THERMO FISHER SCIENTIFIC INC. |
|---|
| Exchange | NYSE |
|---|
| Headquarters | WALTHAM, MA |
|---|
Income statement — period ending 2026-06-27
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $1,773,000,000 |
|---|
| Earnings Per Share, Basic | 5 USD/shares |
|---|
| Earnings Per Share, Diluted | 5 USD/shares |
|---|
| Income (Loss) from Equity Method Investments | -$15,000,000 |
|---|
| Income Tax Expense (Benefit) | $167,000,000 |
|---|
| InterestExpenseNonoperating | $755,000,000 |
|---|
| Investment Income, Interest | $440,000,000 |
|---|
| Net Income (Loss) Attributable to Parent | $1,736,000,000 |
|---|
| Net Income (Loss) Attributable to Noncontrolling Interest | $5,000,000 |
|---|
| Operating Income (Loss) | $2,087,000,000 |
|---|
| Other Nonoperating Income (Expense) | $22,000,000 |
|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,741,000,000 |
|---|
| Research and Development Expense | $364,000,000 |
|---|
| Restructuring Charges | $72,000,000 |
|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $11,994,000,000 |
|---|
| Selling, General and Administrative Expense | $2,333,000,000 |
|---|
| Share-based Payment Arrangement, Noncash Expense | $165,000,000 |
|---|
| Weighted Average Number of Shares Outstanding, Diluted | 371,000,000 shares |
|---|
| Weighted Average Number of Shares Outstanding, Basic | 371,000,000 shares |
|---|
Sourced from SEC EDGAR/XBRL filings via StockSpectro.
View full interactive research on StockSpectro